Pharmaceutical Technology

JUNE 12, 2025

Novo Nordisk is eyeing a cardiometabolic drug market future that is not purely dominated by incretins, after signing a $812m partnership with Deep Apple Therapeutics to access novel compounds for obesity and other diseases. Give your business an edge with our leading industry insights.

Compounding

Pharmaceutical Technology

JUNE 18, 2025

It recently initiated two more Phase III trials of its candidate CagriSema, as well as inking an $812m partnership with Deep Apple Therapeutics to access novel compounds, not GLP-1RAs, for obesity and other diseases. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 12, 2025

Tariffs and trade disputes are further compounding this challenge, affecting the cost structure of pharma businesses. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. Sign up for our daily news round-up!

Health and Personal Care Stores

Pharmaceutical Technology

JULY 2, 2025

The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn.

Packaging

Pharmaceutical Technology

JUNE 30, 2025

The planned 160,000ft² facility will focus on aseptic production and includes areas for material preparation and compounding. June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bird’s-eye view of the current Vetter site in Des Plaines where the clinical manufacturing facility will be built.

Packaging

Pharmaceutical Technology

JUNE 13, 2025

CSPC will use its AI-powered drug discovery platform, which uses the technology to analyse the binding patterns of target proteins with existing compound molecules. The AI models work out targeted optimisation, advancing small molecules with the best developability. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 27, 2025

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and Mounjaro, what happens now? Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 receptor agonists (GLP-1RA), due to the emergence of compounded alternatives in the past few years.

Compounding

Pharmaceutical Technology

JUNE 27, 2025

In March 2025, Novo Nordisk discounted the cost of all doses to $499 per month to competitively price its prized asset against cheaper compounded alternatives. Compounded semaglutide is a personalised weight loss medicine, which is chemically identical to branded alternatives.

Compounding

Pharmaceutical Technology

JUNE 13, 2025

The myasthenia gravis (MG) market across the seven major markets (7MM: France, Germany, Italy, Japan, Spain, the UK and the US) is poised to grow at a compound annual growth rate of 5.3% Credit: Vitalii Vodolazskyi via Shutterstock. billion in 2024 to $10.3 Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JULY 8, 2025

The pulmonary arterial hypertension (PAH) market is forecast to grow at a compound annual growth rate (CAGR) of 2.0% Symptoms such as fatigue, breathlessness, and chest pain are frequently misattributed to more common conditions, delaying intervention and compounding disease burden. Credit: Green Apple via Shutterstock.

Packaging

Pharmaceutical Technology

JULY 30, 2025

By GlobalData Learn more about Strategic Intelligence Lower sales have not solely been caused by Eli Lilly – the rise in compounded semaglutide has eroded market share for Novo Nordisk. The company has maintained that continued compounding is unlawful and unsafe. Give your business an edge with our leading industry insights.

Compounding

Pharmaceutical Technology

JULY 10, 2025

Ross Law July 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The global oncology market is set to grow at a compound annual growth rate (CAGR) of 24.5%. Image credit: CI Photos / Shutterstock. Give your business an edge with our leading industry insights.

Packaging

ISPE

AUGUST 1, 2023

Download White Paper To download this white paper, complete the form below. Once submitted, you will receive a link via the email you provided to download the white paper. You may unsubscribe from these ISPE communications at any time. Leave this field blank Product Development ATMPs Biotech

Compounding

Pharmaceutical Technology

FEBRUARY 23, 2023

Our chemists and formulation scientists review the properties of new drug candidates and “work their magic” to develop formulations that improve the exposure profile of the compound. How does bioavailability play a role in biopharmaceutics? Now fraction absorbed and bioavailability are often confused and used interchangeably.

Compounding

pharmaphorum

NOVEMBER 3, 2021

Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.

Pharmaceutical Companies

ISPE

MAY 3, 2023

Online TOC Comparison: Sensors and Analyzers Trudy Patterson Wed, 05/03/2023 - 16:00 White Paper — Sponsored Content Online TOC Comparison: Sensors and Analyzers 1 May 2023 This application note shows how TOC analyzers and common sensors in the industry recover 11 different compounds most often used in water and product analysis.

Compounding

ISPE

OCTOBER 1, 2022

With more than 400 registered gene therapy clinical trials worldwide and a compound annual growth rate of more than 25% since 2015, there is no doubting the impact of cell and gene therapy (CGT) innovation on the market. Download White Paper. To download this white paper, complete the form below.

Compounding

Pharmaceutical Technology

MARCH 6, 2023

Teijin Pharma is laying the foundation for quickly delivering a new therapy for patients globally by licensing the investigational compound to Novartis. It stated that the candidate is believed to impact the pathogenesis of several kidney diseases and works in a genetically validated pathway.

Compounding

Pharmaceutical Technology

JANUARY 10, 2023

The collaboration will combine 3T Biosciences’ 3T- T-Cell Receptor Antigen and Cross-Reactivity Engine (TRACE) discovery platform with Boehringer Ingelheim’s two-pronged research strategy combining compounds that are directed towards cancer cells and target immune cells.

Immunization

Pharmaceutical Technology

MARCH 20, 2023

These are mainly all those with a compound in BioNTech’s pipeline. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Compounding

Pharmaceutical Technology

DECEMBER 15, 2022

From alcohols to quaternary ammonium compounds, each type of agent has a unique mode of action, with varying degrees of efficacy. It is also essential to evaluate the reliability of the company supplying the ingredient: do they provide sufficient communication and documentation? There are many other aspects to take into consideration.

Documentation

Pharmaceutical Technology

DECEMBER 26, 2022

Faster innovations and continual growth spell benefits for consumers, and these benefits can be compounded, with scope to offer more granularity of services. For example, during the pandemic, companies were facing mass deferrals which required the ability to quickly scale. Please check your email to download the Whitepaper.

Communication

Pharmaceutical Technology

DECEMBER 21, 2022

Faster innovations and continual growth spell benefits for consumers, and these benefits can be compounded, with scope to offer more granularity of services. For example, during the pandemic, companies were facing mass deferrals which required the ability to quickly scale. Please check your email to download the Whitepaper.

Communication

ISPE

MARCH 29, 2023

Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2. Currently, it takes time and/or communications (e.g., July–August 2020).

Documentation

ISPE

MARCH 29, 2023

Ultimately, the summary was not adopted during the QbD pilot, but was reintroduced in 2014 when a Pharmaceutical Research and Manufacturers of America (PhRMA) team prepared a white paper describing the content and format of an improved Module 2. Currently, it takes time and/or communications (e.g., July–August 2020).

Documentation

Pharmaceutical Technology

MARCH 22, 2023

When it comes to highly sensitive large-molecule drugs, sourcing premium elastomeric components with a cleaner compound, such as Datwyler’s FM457, is an essential step in reducing the E&L risk. Another step is to source the highest quality components available on the market. Please check your email to download the Webinar.

Packaging

ISPE

SEPTEMBER 11, 2023

Examples include platforms as small as autonomous units placed within a facility and mobile production trailers for compounding to platforms as large as a prefabricated, self-contained GMP facility. Nature Communications 12, no. EFPIA White Paper on CMC Development, Manufacture and Supply of Pandemic COVID-19 Therapies and Vaccines.”

Health and Personal Care Stores